Dr Agarwals Eye Hospital Ltd (DRAGARWQ) — shareholding pattern, promoter holding, financials and share price
About Dr Agarwals Eye Hospital Ltd (DRAGARWQ)
Dr Agarwals Eye Hospital Ltd operates in the Hospital industry, within the Healthcare sector. It trades on the NSE as DRAGARWQ and on the BSE under scrip code 526783. Its ISIN is INE934C01018.
Dr Agarwal's Eye Hospital Ltd is a leading chain of eye hospitals with predominant presence in Tamil Nadu. [1]
Dr. Agarwal's Health Care Limited is India's largest eye care service chain by revenue, providing comprehensive services like surgeries, consultations, and optical sales.
The company is undergoing a merger with Dr. Agarwal's Eye Hospital Limited, consolidating operations to enhance service delivery and market presence across India and Africa.
Listed peers in Hospital: Indraprastha Medical Corporation Ltd, KMC Speciality Hospitals (India) Ltd, Shalby Ltd, Unihealth Hospitals Ltd, GPT Healthcare Ltd, Gujarat Kidney & Super Speciality Ltd.
Valuation & Returns
10 Jul 2026At ₹4,895.95 a share on 10 Jul 2026, Dr Agarwals Eye Hospital Ltd (DRAGARWQ) was valued at a price-to-earnings ratio of 33.75x against an industry P/E of 61.73x and a price-to-book of 11.29x on a book value of ₹433.72 per share as of Mar 2025. Solomo computes return on equity of 33.44% and return on capital employed of 19.44% from filed results. Earnings ratios use standalone results for the twelve months Jun 2025 to Mar 2026.
- P/E
- 33.75x
- Industry P/E
- 61.73x
- P/B
- 11.29x
- EPS (TTM)
- ₹145.05
- Book value / share
- ₹433.72
- ROE
- 33.44%
- ROCE
- 19.44%
- ROA
- 11.43%
- Debt / equity
- 1.59x
- Dividend yield
- 0.13%
- EBITDA margin
- 32.1%
- 52-week range
- ₹4,231 – ₹6,392
Ratios are computed from filed results and the last recorded price. Not investment advice.
Financial Performance
Mar 2026In the year ended Mar 2026, Dr Agarwals Eye Hospital Ltd (DRAGARWQ) reported revenue of ₹471 crore, net profit of ₹70 crore and earnings per share of ₹145.05. That compares with revenue of ₹397 crore and net profit of ₹55 crore in Mar 2025. Figures are standalone, as filed with the exchanges.
In the quarter ended Mar 2026, revenue was ₹120 crore and net profit ₹16 crore (standalone).
| Metric | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Revenue (₹ cr) | 201 | 268 | 319 | 397 | 471 |
| Net profit (₹ cr) | 24 | 37 | 46 | 55 | 70 |
| EPS (₹) | 51.28 | 78.55 | 98.64 | 116.28 | 145.05 |
| Measure | 10Y | 5Y | 3Y | 1Y |
|---|---|---|---|---|
| Sales growth | 12.59% | 17.68% | 25.44% | 24.38% |
| Profit growth | 125.19% | 31.91% | 31.38% | 17.88% |
Ownership Summary
Jun 2026As of Jun 2026, promoters hold 72.67% of Dr Agarwals Eye Hospital Ltd (DRAGARWQ) (unchanged from the previous quarter), foreign institutional investors (FII) hold 2.24% and domestic institutional investors (DII) hold 2.05%. Promoters have pledged 7.7% of their holding. Market capitalisation was ₹2,366 crore on 10 Jul 2026. Shareholding is filed quarterly with BSE and NSE; Solomo carries every filing back to Mar 2001.
Largest disclosed public shareholders in Jun 2026: INVESTOR EDUCATION AND PROTECTION FUND AUTHORITY MINISTRY OF CORPORATE AFFAIRS 2.7%, MALABAR INDIA FUND LIMITED 2.16%, VARUN ASHOK HIREMATH 2.11%, MALABAR MIDCAP FUND 1.66%. Only stakes above the 1% disclosure threshold are named in filings.
| Quarter | Promoter | Pledged | FII | DII | Public |
|---|---|---|---|---|---|
| Jun 2026 | 72.67% | 7.7% | 2.24% | 2.05% | 27.33% |
| Mar 2026 | 72.67% | 29.3% | 2.2% | 2.12% | 27.33% |
| Dec 2025 | 72.67% | 29.3% | 1.82% | 2.36% | 27.33% |
| Sep 2025 | 72.67% | 29.3% | 1.74% | 2.36% | 27.33% |
| Jun 2025 | 71.9% | 55.4% | 1.5% | 2.31% | 28.1% |
| Mar 2025 | 71.9% | 55.4% | 1.33% | 1.95% | 28.1% |
| Dec 2024 | 71.9% | 55.4% | 0.84% | 1.03% | 28.1% |
| Sep 2024 | 71.9% | 55.4% | 0.83% | 0.96% | 28.1% |